OCGN
Ocugen, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.36
+0.74%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 82.93x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -27.86x
- Price / sales
- 100.70x
- Price / cash flow
- -7.53x
Enterprise value
- Enterprise value
- $449.1M
- EV / sales
- 98.06x
- EV / EBITDA
- -6.40x
- EV / EBIT
- -6.52x
- Market cap
- $461.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026